
Circulating Tumor DNA (ctDNA) detection is a molecular diagnostic technique that identifies tumor-specific genetic mutations in the DNA fragments released into the bloodstream by cancer cells. It can provide insights into cancer progression and treatment response.
The global ctDNA Detection market was valued at US$ 1327 million in 2023 and is anticipated to reach US$ 3600.6 million by 2030, witnessing a CAGR of 15.7% during the forecast period 2024-2030.
North American market for ctDNA Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ctDNA Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ctDNA Detection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ctDNA Detection include Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, Johnson & Johnson, Amoy Diagnostics, Annaroad Gene Technology and Burning Rock Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ctDNA Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ctDNA Detection.
Report Scope
The ctDNA Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ctDNA Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ctDNA Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
Johnson & Johnson
Amoy Diagnostics
Annaroad Gene Technology
Burning Rock Biotech
Segment by Type
Independent Detection
Joint Detection
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ctDNA Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ctDNA Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Independent Detection
1.2.3 Joint Detection
1.3 Market by Application
1.3.1 Global ctDNA Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ctDNA Detection Market Perspective (2019-2030)
2.2 ctDNA Detection Growth Trends by Region
2.2.1 Global ctDNA Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ctDNA Detection Historic Market Size by Region (2019-2024)
2.2.3 ctDNA Detection Forecasted Market Size by Region (2025-2030)
2.3 ctDNA Detection Market Dynamics
2.3.1 ctDNA Detection Industry Trends
2.3.2 ctDNA Detection Market Drivers
2.3.3 ctDNA Detection Market Challenges
2.3.4 ctDNA Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ctDNA Detection Players by Revenue
3.1.1 Global Top ctDNA Detection Players by Revenue (2019-2024)
3.1.2 Global ctDNA Detection Revenue Market Share by Players (2019-2024)
3.2 Global ctDNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ctDNA Detection Revenue
3.4 Global ctDNA Detection Market Concentration Ratio
3.4.1 Global ctDNA Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ctDNA Detection Revenue in 2023
3.5 ctDNA Detection Key Players Head office and Area Served
3.6 Key Players ctDNA Detection Product Solution and Service
3.7 Date of Enter into ctDNA Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ctDNA Detection Breakdown Data by Type
4.1 Global ctDNA Detection Historic Market Size by Type (2019-2024)
4.2 Global ctDNA Detection Forecasted Market Size by Type (2025-2030)
5 ctDNA Detection Breakdown Data by Application
5.1 Global ctDNA Detection Historic Market Size by Application (2019-2024)
5.2 Global ctDNA Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ctDNA Detection Market Size (2019-2030)
6.2 North America ctDNA Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ctDNA Detection Market Size by Country (2019-2024)
6.4 North America ctDNA Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ctDNA Detection Market Size (2019-2030)
7.2 Europe ctDNA Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ctDNA Detection Market Size by Country (2019-2024)
7.4 Europe ctDNA Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ctDNA Detection Market Size (2019-2030)
8.2 Asia-Pacific ctDNA Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ctDNA Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific ctDNA Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ctDNA Detection Market Size (2019-2030)
9.2 Latin America ctDNA Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ctDNA Detection Market Size by Country (2019-2024)
9.4 Latin America ctDNA Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ctDNA Detection Market Size (2019-2030)
10.2 Middle East & Africa ctDNA Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ctDNA Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa ctDNA Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad ctDNA Detection Introduction
11.1.4 Bio-Rad Revenue in ctDNA Detection Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche ctDNA Detection Introduction
11.2.4 Roche Revenue in ctDNA Detection Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Biocartis
11.3.1 Biocartis Company Detail
11.3.2 Biocartis Business Overview
11.3.3 Biocartis ctDNA Detection Introduction
11.3.4 Biocartis Revenue in ctDNA Detection Business (2019-2024)
11.3.5 Biocartis Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen ctDNA Detection Introduction
11.4.4 Qiagen Revenue in ctDNA Detection Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Detail
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health ctDNA Detection Introduction
11.5.4 Guardant Health Revenue in ctDNA Detection Business (2019-2024)
11.5.5 Guardant Health Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson ctDNA Detection Introduction
11.6.4 Johnson & Johnson Revenue in ctDNA Detection Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Amoy Diagnostics
11.7.1 Amoy Diagnostics Company Detail
11.7.2 Amoy Diagnostics Business Overview
11.7.3 Amoy Diagnostics ctDNA Detection Introduction
11.7.4 Amoy Diagnostics Revenue in ctDNA Detection Business (2019-2024)
11.7.5 Amoy Diagnostics Recent Development
11.8 Annaroad Gene Technology
11.8.1 Annaroad Gene Technology Company Detail
11.8.2 Annaroad Gene Technology Business Overview
11.8.3 Annaroad Gene Technology ctDNA Detection Introduction
11.8.4 Annaroad Gene Technology Revenue in ctDNA Detection Business (2019-2024)
11.8.5 Annaroad Gene Technology Recent Development
11.9 Burning Rock Biotech
11.9.1 Burning Rock Biotech Company Detail
11.9.2 Burning Rock Biotech Business Overview
11.9.3 Burning Rock Biotech ctDNA Detection Introduction
11.9.4 Burning Rock Biotech Revenue in ctDNA Detection Business (2019-2024)
11.9.5 Burning Rock Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
Johnson & Johnson
Amoy Diagnostics
Annaroad Gene Technology
Burning Rock Biotech
Ìý
Ìý
*If Applicable.
